Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

21.00 

0.30 1.5%

as of Mar 04 '21

52 Week Range:

0.14 24.50


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Chargemaster Toolkit, an automated software-as-a-service (SaaS) chargemaster management solution for capturing optimal legitimate reimbursement for providers; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Reference Plus, a SaaS solution to perform chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; interface scripting module, a software that automatically uploads chargemaster changes to the patient billing system for accurate billing; Trisus Pricing Analyzer, a SaaS solution that simplifies the price modelling process; and Online Reference Toolkit and supplies assistant solutions. It also offers InSight Medical Necessity, a SaaS solution that provides medical necessity validation for the United States payors and advance beneficiary notice creation; Trisus Claims Informatics, a software that automates claim and coding reviews; and InSight Audit, a web-based audit management application for healthcare organizations to manage government and commercial audits. In addition, the company provides Trisus Healthcare Intelligence, a cost analytics and resource efficiency platform; Patient Charge Estimator to simplify the process of providing patient bill estimates for inpatient and outpatient services; InSight Denials to analyze, track, trend, and report on denial data; and appeals services. Further, it offers consulting and professional services; and sales and marketing, product development, and software development services. Craneware plc was founded in 1999 and is headquartered in Edinburgh, the United Kingdom.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20
Equity (BVPS) 0.57
0.75
0.79
0.93
0.92
1.05
1.38
1.49
1.81
1.66
2.01
growth rate 31.6% 5.3% 17.7% -1.1% 14.1% 31.4% 8.0% 21.5% -8.3% 21.1%
Earnings BIT 4.47
5.32
6.89
11.00
11.27
12.57
14.41
16.50
18.59
19.24
19.22
growth rate 19.1% 29.5% 59.5% 2.5% 11.5% 14.7% 14.5% 12.7% 3.5% -0.1%
Avg.PE 28.82
41.67
13.44
17.04
12.32
0.20
23.28
31.25
52.68
40.00
23.26
growth rate 44.6% -67.8% 26.8% -27.7% -98.4% 11,540.0% 34.2% 68.6% -24.1% -41.9%
ROA 14.74
12.19
15.04
13.25
12.55
12.43
12.30
14.17
16.11
14.60
15.16
growth rate -17.3% 23.4% -11.9% -5.3% -1.0% -1.1% 15.2% 13.7% -9.4% 3.8%
ROE 27.13
22.09
25.47
21.07
19.97
20.29
21.06
24.12
28.46
26.88
26.26
growth rate -18.6% 15.3% -17.3% -5.2% 1.6% 3.8% 14.5% 18.0% -5.6% -2.3%
ROIC 26.40
21.86
25.22
20.86
19.85
20.15
20.89
23.75
28.10
26.42
24.97
growth rate -17.2% 15.4% -17.3% -4.8% 1.5% 3.7% 13.7% 18.3% -6.0% -5.5%
Cur. Ratio 2.00
1.57
1.78
1.99
2.08
1.91
1.70
1.81
1.38
1.43
1.52
growth rate -21.5% 13.4% 11.8% 4.5% -8.2% -11.0% 6.5% -23.8% 3.6% 6.3%
Quick Ratio 1.93
1.37
1.56
1.97
2.05
1.88
1.67
1.77
1.33
1.38
1.47
growth rate -29.0% 13.9% 26.3% 4.1% -8.3% -11.2% 6.0% -24.9% 3.8% 6.5%
Leverage 1.87
1.77
1.63
1.56
1.62
1.64
1.78
1.64
1.92
1.78
1.69
growth rate -5.4% -7.9% -4.3% 3.9% 1.2% 8.5% -7.9% 17.1% -7.3% -5.1%
Balance Sheet Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20
Acct.Receivable 7.10
8.00
8.00
9.00
16.67
11.98
18.00
13.56
10.60
16.87
18.95
growth rate 12.7% 0.0% 12.5% 85.3% -28.2% 50.3% -24.7% -21.8% 59.1% 12.4%
Acct.Payable 1.00
1.00
2.00
1.23
1.34
1.47
0.76
0.82
1.71
0.72
growth rate 0.0% 100.0% -38.6% 9.2% 9.8% -48.5% 8.6% 107.3% -57.9%
Cur.Assets 38.00
37.00
42.00
46.00
53.67
56.84
69.77
68.55
65.34
66.40
68.85
growth rate -2.6% 13.5% 9.5% 16.7% 5.9% 22.7% -1.7% -4.7% 1.6% 3.7%
Total Assets 25.42
57.00
61.00
64.00
72.86
78.22
93.78
97.15
98.93
106.30
115.76
growth rate 124.2% 7.0% 4.9% 13.8% 7.4% 19.9% 3.6% 1.8% 7.5% 8.9%
Cash 18.10
24.00
29.00
30.00
32.61
41.83
48.81
53.17
52.83
47.61
47.85
growth rate 32.6% 20.8% 3.5% 8.7% 28.3% 16.7% 8.9% -0.6% -9.9% 0.5%
Inventory 0.00 0.00 0.00
growth rate
Cur.Liabilities 19.00
24.00
24.00
23.00
25.86
29.77
40.97
37.80
47.29
46.47
45.35
growth rate 26.3% 0.0% -4.2% 12.5% 15.1% 37.6% -7.7% 25.1% -1.7% -2.4%
Liabilities 11.88
25.00
24.00
23.00
27.94
30.59
40.97
37.80
47.29
46.47
47.36
growth rate 110.4% -4.0% -4.2% 21.5% 9.5% 33.9% -7.8% 25.1% -1.7% 1.9%
LT Debt 0.00 0.00 0.00
growth rate
Equity 13.60
19.95
23.02
25.42
44.92
47.63
52.81
59.36
51.65
59.84
68.40
growth rate 46.6% 15.4% 10.4% 76.7% 6.0% 10.9% 12.4% -13.0% 15.9% 14.3%
Common Shares 26.00
26.00
27.00
27.00
27.00
27.00
27.00
28.00
27.00
27.00
27.00
growth rate 0.0% 3.9% 0.0% 0.0% 0.0% 0.0% 3.7% -3.6% 0.0% 0.0%
Cash Flow Statement Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20
Capital Expenditures 0.37
2.00
0.25
0.12
0.31
0.38
0.42
0.65
0.43
0.65
0.19
growth rate 441.4% -87.7% -50.0% 150.2% 22.7% 10.6% 56.5% -33.6% 50.7% -71.4%
Cash Dividends 1.85
1.91
2.52
2.89
5.36
5.39
5.95
6.36
7.82
8.50
9.08
growth rate 3.3% 32.3% 14.6% 85.2% 0.5% 10.5% 6.8% 23.0% 8.7% 6.8%
Cash From OA 4.12
9.00
9.00
7.00
8.11
19.58
15.42
17.85
29.99
13.46
20.67
growth rate 118.2% 0.0% -22.2% 15.8% 141.5% -21.2% 15.8% 68.0% -55.1% 53.5%
FCF per Share 0.15
0.15
0.11
0.23
0.15
0.35
0.39
0.25
0.39
0.36
0.44
growth rate 0.0% -26.7% 109.1% -34.8% 133.3% 11.4% -35.9% 56.0% -7.7% 22.2%
Sale Purchase of Stock 0.04
0.04
0.10
0.52
growth rate 0.0% 137.5% 451.6%
FCF 6.00
6.00
9.00
6.00
8.00
18.00
13.00
13.00
25.00
3.00
11.00
growth rate 0.0% 50.0% -33.3% 33.3% 125.0% -27.8% 0.0% 92.3% -88.0% 266.7%
Income Statement Jun '10 Jun '11 Jun '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20
Sales 17.48
38.00
41.00
41.00
42.57
44.82
49.85
57.80
67.07
71.40
71.49
growth rate 117.4% 7.9% 0.0% 3.8% 5.3% 11.2% 16.0% 16.0% 6.5% 0.1%
Op.Income 4.37
6.00
9.00
11.00
11.27
12.57
14.41
16.50
18.59
19.24
19.22
growth rate 37.3% 50.0% 22.2% 2.5% 11.5% 14.7% 14.5% 12.7% 3.5% -0.1%
IBT 4.49
5.36
6.89
6.53
11.29
12.50
13.92
16.88
18.93
18.32
19.30
growth rate 19.2% 28.7% -5.4% 73.0% 10.7% 11.4% 21.3% 12.1% -3.2% 5.4%
Net Income 3.39
6.00
9.00
8.00
8.61
9.39
10.58
13.53
15.80
14.99
16.84
growth rate 77.2% 50.0% -11.1% 7.6% 9.0% 12.6% 27.9% 16.8% -5.1% 12.4%
EPS 0.21
0.23
0.33
0.30
0.32
0.34
0.39
0.49
0.57
0.55
0.61
growth rate 9.5% 43.5% -9.1% 6.7% 6.3% 14.7% 25.6% 16.3% -3.5% 10.9%
Gross Profit 15.88
33.00
40.00
39.00
40.63
42.40
46.84
54.21
63.66
67.01
66.97
growth rate 107.8% 21.2% -2.5% 4.2% 4.3% 10.5% 15.8% 17.4% 5.3% -0.1%
R&D 2.34
3.08
4.19
4.25
6.98
6.99
7.67
9.11
13.17
10.41
12.27
growth rate 31.6% 36.0% 1.5% 64.3% 0.1% 9.8% 18.8% 44.6% -21.0% 17.9%

Quarterly Statements

Item Name Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Earnings BIT 5.03
4.74
4.74
4.87
4.87
growth rate -5.7% 0.0% 2.6% 0.0%
Balance Sheet Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Acct.Receivable 16.87
20.15
20.15
18.95
18.95
growth rate 19.5% 0.0% -6.0% 0.0%
Acct.Payable 1.71
1.03
1.03
0.72
0.72
growth rate -40.0% 0.0% -29.9% 0.0%
Cur.Assets 66.40
65.97
65.97
68.85
68.85
growth rate -0.6% 0.0% 4.4% 0.0%
Total Assets 106.30
112.54
112.54
115.76
115.76
growth rate 5.9% 0.0% 2.9% 0.0%
Cash 47.61
44.97
44.97
47.85
47.85
growth rate -5.5% 0.0% 6.4% 0.0%
Cur.Liabilities 46.47
43.48
43.48
45.35
45.35
growth rate -6.4% 0.0% 4.3% 0.0%
Liabilities 46.47
46.05
46.05
47.36
47.36
growth rate -0.9% 0.0% 2.9% 0.0%
Equity 59.84
66.49
66.49
68.40
68.40
growth rate 11.1% 0.0% 2.9% 0.0%
Common Shares 0.54
0.54
0.54
0.54
0.54
growth rate 0.2% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Capital Expenditures 0.11
0.02
0.02
0.08
0.08
growth rate -84.4% 0.0% 350.0% 0.0%
Cash Dividends 1.89
2.66
2.66
1.88
1.88
growth rate 40.4% 0.0% -29.1% 0.0%
Cash From OA 9.14
3.21
3.21
7.13
7.13
growth rate -65.0% 0.0% 122.4% 0.0%
Sale Purchase of Stock
growth rate
FCF 9.04
3.19
3.19
7.05
7.05
growth rate -64.7% 0.0% 121.2% 0.0%
Income Statement Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Sales 17.77
17.93
17.93
17.81
17.81
growth rate 0.9% 0.0% -0.7% 0.0%
Op.Income 5.03
4.74
4.74
4.87
4.87
growth rate -5.7% 0.0% 2.6% 0.0%
IBT 4.51
4.80
4.80
4.85
4.85
growth rate 6.4% 0.0% 1.0% 0.0%
Net Income 3.64
3.99
3.99
4.43
4.43
growth rate 9.6% 0.0% 11.1% 0.0%
Gross Profit 16.72
16.91
16.91
16.58
16.58
growth rate 1.1% 0.0% -2.0% 0.0%
R&D 5.20
6.13
6.13
6.13
6.13
growth rate 17.9% 0.0% 0.0% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (64.80)

YOY Growth Grade:

C (58.78)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 33.76 33.93 25.80
EPS / Growth 9.6% 0.62 25.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 11.8%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 9.6% 10.7% 10.7%
Future PE 19.20 26.97 26.97
Future EPS 1.55 1.71 1.71
Value Price
MOS %
7.35
-65.0%
11.39
-45.8%
11.39
-45.8%
MOS Price 3.67 5.69 5.69
IRT 15.04 14.30 14.30

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.